New Frontiers in Inflammatory Bowel Disease Monitoring

THE GLOBAL health burden of inflammatory bowel disease (IBD) is increasingly prevalent in today’s world, partly due to unhealthy lifestyle choices and growing obesity rates. The remitting and relapsing nature of IBD means treatment is complicated and non-linear. Coupled with the complex interactions between genetic and lifestyle factors, a streamlined approach to treatment is yet to be defined. Nevertheless, there have been huge advancements in the field, with several key publications paving the way in IBD research. Experts at United European Gastroenterology (UEG) Week 2024 highlighted several of the latest key advancements, and hinted at what’s to come for IBD management in the coming years.